MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
INTS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Intensity Therapeutics (INTS) Ownership - Who owns Intensity Therapeutics?

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
16
Web
https://www.intensitytherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.89M
P/E Ratio
-1.51
Total Cash
9.53M
Projected Growth
N/A
Total Debt
95K
Revenue
N/A
Risk (Beta)
3.02
Dividend Yield
N/A
Total Cash/Share
2.92
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
INTS
Alerts
Alerts
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI Trading Bots for INTS
Related Blogs
ABEO

Abeona Therapeutics (ABEO) Shares Decline -52% in 30 Days After Q3 Update and Financing News

FTH

Faeth Therapeutics (FTH) Analyst Consensus at $61: Assessing the Path to +381% Upside

FDMT

4D Molecular Therapeutics (FDMT): What Investors Should Watch in the Q3 2026 Report

MTVA

MetaVia Inc. (MTVA): Examining a Biotech's Cardiometabolic Drug Pipeline

RZLT

Rezolute (RZLT) Reports In-Line Q1 Loss as Pipeline Milestones Draw Nearer

View all blogs related to
#Biotechnology
Interesting Articles

What does “Buy-Side” Mean?

Should I Rely on Analyst Upgrades or Downgrades of the Positions in my Investment Portfolio?

What is “adding to a loser”?

What Qualifies You as a "Trader," and How Do You Report Income and Expenses?

Understanding 401(k) Reports: A Step-by-Step Guide to Utilizing Them Effectively

View all articles
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
16
Web
https://www.intensitytherapeutics.com
Who owns Intensity Therapeutics? INTS symbol Ownership - Tickeron.com